Abstract
Hepatic steatosis is an early form of non-alcoholic fatty liver disease (NAFLD), caused by abnormal fat deposition in the hepatocytes. Conjugated linoleic acid (CLA) is a group of positional and geometric dienoic isomers of linoleic acid that attract significant attention because of its beneficial effects on chronic diseases such as cancer, obesity, and metabolic syndrome. This study examined the influence of a mixture of two main CLA isomers (CLA-mix) on lipid accumulation and lipid metabolism-related genes using HepG2 cells treated with palmitic acid (PA) as an in vitro model for hepatic steatosis. Methods and Results: HepG2 cells were treated for 24 h: control (BSA), model (BSA + PA), and treated groups (BSA-PA + non-toxic concentrations of CLA-mix). Intracellular lipid deposition, triglyceride (TG), total cholesterol (TC) and gene expression were measured by Oil-Red O staining, colorimetric assay kits and real-time PCR, respectively. CLA-mix at high concentrations had significantly decreased intracellular total lipid and TG deposition compared to the model group. However, none of the CLA-mix concentrations had a significant effect on the intracellular TC level. CLA-mix significantly increased the expression of some genes mainly regulated by PPARα but did not alter the expression of lipogenesis-related genes. Conclusions: These results demonstrate that high concentrations of CLA-mix protect against hepatic steatosis and play a role in regulating fatty acid oxidation and bile excretion through the PPARα pathway. It is suggested that the effect of different ratios of two main CLA isomers on the amount and ratio of bile compounds be investigated in future studies.
Graphic abstract
Similar content being viewed by others
Data availability
Data of this study are included in the article and the primary data can be provided from the corresponding author.
Abbreviations
- ACC:
-
Acetyl-CoA carboxylase
- AA:
-
Arachidonic acid
- ABCG8:
-
ATP binding cassette subfamily G member 8
- BA:
-
Bile acid
- BSEP:
-
Bile salt export pump
- BSA:
-
Bovine serum albumin
- CPT-1:
-
Carnitine palmitoyltransferase-I:
- Chol:
-
Cholesterol
- CAA:
-
Conjugated arachidonic acid
- CLA:
-
Conjugated linoleic acid
- FXR:
-
Farnesoid X receptor
- FABP:
-
Fatty acid-binding protein
- FAS:
-
Fatty acid synthase
- FFA:
-
Free fatty acid
- Glc:
-
Glucose
- Gly:
-
Glycerol
- HMGCR:
-
3-Hydroxy-3methyl-glutaryl-coenzyme A reductase
- HMGCS2:
-
3-Hydroxy-3-methylglutaryl-coa synthase 2
- LA:
-
Linoleic acid
- LPL:
-
Lipoprotein lipase
- LXRα:
-
Liver X receptor alpha
- MDR3:
-
Multidrug resistance protein 3
- NAFLD:
-
Non-alcoholic fatty liver disease
- NASH:
-
Non-alcoholic steatohepatitis
- OA:
-
Oleic acid
- PA:
-
Palmitic acid
- ACOX1:
-
Peroxisomal acyl-coenzyme A oxidase1
- α:
-
β, γ1, γ2, Peroxisome proliferator-activated receptors
- PL:
-
Phospholipid
- SA:
-
Stearic acid
- SREBP-1c:
-
Sterol-regulatory element binding protein-1c
- TG:
-
Triglyceride
- TC:
-
Total cholesterol
- UCP:
-
Uncoupling protein
- VLDL:
-
Very low density lipoprotein
References
Sinton MC, Hay DC, Drake AJ (2019) Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. Clin Epigenetics 11(1):104. https://doi.org/10.1186/s13148-019-0702-5
Pierantonelli I, Svegliati-Baroni G (2019) Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH. Transplantation 103(1):e1–e13
Lopez-Velazquez JA, Silva-Vidal KV, Ponciano-Rodriguez G, Chávez-Tapia NC, Arrese M, Uribe M, Méndez-Sánchez N (2014) The prevalence of nonalcoholic fatty liver disease in the Americas. Ann hepatol 13(2):166–178
Oseini AM, Sanyal AJ (2017) Therapies in non-alcoholic steatohepatitis (NASH). Liver Int 37(Suppl 1):97–103. https://doi.org/10.1111/liv.13302
Churruca I, Fernández-Quintela A, Portillo MP (2009) Conjugated linoleic acid isomers: differences in metabolism and biological effects. BioFactors 35(1):105–111
Banni S (2002) Conjugated linoleic acid metabolism. CurrOpinLipidol 13(3):261–266
Chinnadurai K, Tyagi A (2011) Conjugated linoleic acid: a milk fatty acid with unique health benefit properties. Soybean and Health, 111
Kim JH, Kim Y, Kim YJ, Park Y (2016) Conjugated linoleic acid: potential health benefits as a functional food ingredient. Ann Rev Food SciTechnol 7:221–244
den Hartigh LJ (2019) Conjugated linoleic acid effects on cancer, obesity, and atherosclerosis: a review of pre-clinical and human trials with current perspectives. Nutrients 11(2):370
Whigham LD, Watras AC, Schoeller DA (2007) Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J clinNutr 85(5):1203–1211
Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim H-J, Tange T, Okuyama H, Kasai M, Ikemoto S, Ezaki O (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49(9):1534–1542
Clément L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, Staels B, Besnard P (2002) Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43(9):1400–1409
Macarulla MT, Fernández-Quintela A, Zabala A, Navarro V, Echevarría E, Churruca I, Rodríguez VM, Portillo MPJN (2005) Effects of conjugated linoleic acid on liver composition and fatty acid oxidation are isomer-dependent in hamster. Nutrition 21(4):512–519
Purushotham A, Shrode GE, Wendel AA, Liu L-F, Belury MA (2007) Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult wistar rats. J NutrBiochem 18(10):676–684
Noto A, Zahradka P, Yurkova N, Xie X, Nitschmann E, Ogborn M, Taylor CG (2006) Conjugated linoleic acid reduces hepatic steatosis, improves liver function, and favorably modifies lipid metabolism in obese insulin-resistant rats. Lipids 41(2):179–188
Nakamura YK, Flintoff-Dye N, Omaye ST (2008) Conjugated linoleic acid modulation of risk factors associated with atherosclerosis. Nutrmetab 5(1):22
Belury MA (2002) Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 22(1):505–531
Piras A, Carta G, Murru E, Lopes PA, Martins SV, Prates JA, Banni S (2015) Effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese zucker rats. Prostaglandins LeukotEssent Fatty Acids 98:15–19
Cao P, Huang G, Yang Q, Guo J, Su Z (2016) The effect of chitooligosaccharides on oleic acid-induced lipid accumulation in HepG2 cells. Saudi Pharm J 24(3):292–298
Iida KT, Kawakami Y, Suzuki H, Sone H, Shimano H, Toyoshima H, Okuda Y, Yamada N (2002) PPARγ ligands, troglitazone and pioglitazone, up-regulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages. FEBS Lett 520(1–3):177–181
Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Büttner R, Schölmerich J, Hellerbrand C (2009) Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res 19(8):996–1005
Corbett JL, Duncan SA (2019) iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery. Front Med. https://doi.org/10.3389/fmed.2019.00265
Yanagita T, Han S-Y, Hu Y, Nagao K, Kitajima H, Murakami S (2008) Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells. Lipids Health Dis 7(1):38
Wang N, Kong R, Luo H, Xu X, Lu J (2017) Peroxisome proliferator-activated receptors associated with nonalcoholic fatty liver disease. PPAR Res 2017:1–8
Lehnen TE, da Silva MR, Camacho A, Marcadenti A, Lehnen AM (2015) A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism. J IntSoc Sports Nutr 12(1):1–11
Hagen RM, Rhodes A, Ladomery MR (2013) Conjugated linoleate reduces prostate cancer viability whereas the effects of oleate and stearate are cell line-dependent. Anticancer Res 33(10):4395–4400
Bhatia A, Sharma A, Balgir PP, Kapoor D (2015) Anti-cancerous effect of linoleic acid and conjugated linoleic acid on hepatic cancer cells and histocytic lymphoma cells: In vitro. AdvApplSci Res 6(4):114–117
Melaku A, Kadir AA, Othman F, Meng GY, Sazili A (2012) Cytotoxic effects of conjugated linoleic acids on human hepatoma cancer cells (HepG2). J MolPathophysiol 1(1):43–48
Igarashi M, Miyazawa T (2000) Newly recognized cytotoxic effect of conjugated trienoic fatty acids on cultured human tumor cells. Cancer Lett 148(2):173–179
Kineman RD, Majumdar N, Subbaiah PV, Cordoba-Chacon J (2016) Hepatic PPARγ is not essential for the rapid development of steatosis after loss of hepatic GH signaling, in adult male mice. Endocrinology 157(5):1728–1735
Dozsa A, Dezso B, Toth BI, Bacsi A, Poliska S, Camera E, Picardo M, Zouboulis CC, Bíró T, Schmitz G (2014) PPARγ-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytes. J InvestigDermatol 134(4):910–920
Urquhart P, Parkin SM, Rogers JS, Bosley JA, Nicolaou A (2002) The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. BiochimBiophysActa (BBA) 1580(2–3):150–160
House RL, Cassady JP, Eisen EJ, Eling TE, Collins JB, Grissom SF, Odle J (2005) Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. PhysiolGenom 21(3):351–361
Granlund L, Juvet LK, Pedersen JI, Nebb HI (2003) Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARγ modulator. J Lipid Res 44(8):1441–1452
Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML (2003) Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J BiolChem 278(36):34268–34276
Lee YK, Park JE, Lee M, Hardwick JP (2018) Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2. Liver Res 2(4):209–215
Maslak E, Buczek E, Szumny A, Szczepnski W, Franczyk-Zarow M, Kopec A, Chlopicki S, Leszczynska T, Kostogrys RB (2015) Individual CLA isomers, c9t11 and t10c12, prevent excess liver glycogen storage and inhibit lipogenic genes expression induced by high-fructose diet in rats. Biomed Res Int 2015:1–10
Go G-W, Oh S, Park M, Gang G, McLean D, Yang H-S, Song M-H, Kim Y (2013) t10, c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation. J MicrobiolBiotechnol 23(11):1569–1576
Greene ES, Rodriguez-Sallaberry C, Caldari-Torres C, Badinga L (2006) Effects of conjugated linoleic acids on lipid metabolizing genes and high-density lipoprotein cholesterol production in human hepatocytes. J Appl Res ClinExpTher 6(2):132
Yu S, Matsusue K, Kashireddy P, Cao W-Q, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, Reddy JK (2003) Adipocyte-specific gene expression and adipogenicsteatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression. J BiolChem 278(1):498–505
Montagner A, Polizzi A, Fouché E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Régnier M, Lukowicz C, Benhamed F (2016) Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65(7):1202–1214
Armstrong MB, Towle HC (2001) Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARα-mediated pathway. Am J Physiol-EndocrinolMetab 281(6):E1197–E1204
Moya Camarena SY (1998) Evidence for a peroxisome proliferator-activated receptor (PPAR)-mediated mechanism for conjugated linoleic acid (CLA)
Moya-Camarena SY, Heuvel JPV, Belury MA (1999) Conjugated linoleic acid activates peroxisome proliferator-activated receptor α and β subtypes but does not induce hepatic peroxisome proliferation in Sprague–Dawley rats. BiochimBiophysActa (BBA) 1436(3):331–342
Zhao A, Yu J, Lew J-L, Huang L, Wright SD, Cui J (2004) Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. DNA Cell Biol 23(8):519–526
Shoda J, Inada Y, Tsuji A, Kusama H, Ueda T, Ikegami T, Suzuki H, Sugiyama Y, Cohen DE, Tanaka N (2004) Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4. J Lipid Res 45(10):1813
Washington MK (2009) Gallbladder and extrahepatic bile ducts. Modern surgical pathology. Elsevier, Amsterdam, pp 960–975
Gustafsson U, Benthin L, Granström L, Groen AK, Sahlin S, Einarsson C (2005) Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology 41(6):1322–1328
St.George CM, Russell JC, Shaffer EA (1994) Effects of obesity on bile formation and biliary lipid secretion in the genetically obese JCR: LA-corpulent rat. Hepatology 20(6):1541–1547
Rahman SM, Huda MN, Uddin MN, Akhteruzzaman S (2002) Short-term administration of conjugated linoleic acid reduces liver triglyceride concentration and phosphatidatephosphohydrolase activity in OLETF rats. BMB Rep 35(5):494–497
Acknowledgements
This experimental study was part of a Ph.D. program and supported by a grant from the Tehran University of Medical Sciences (TUMS Grant Number: 96-02-30-35441).
Funding
This project was financially supported by grant (TUMS Grant Number: 96-02-30-35441) from the Deputy of Research, Tehran University of Medical Sciences.
Author information
Authors and Affiliations
Contributions
AJ, MP and TG designed the project. AJ carried out all experiments and wrote the manuscript. MP provided all the required materials and advice about this study. TG provided valuable instructions and suggestions for this study. RM Helpful and effective tips during project implementation. NE helped for cell culture and optimizing of MTT assay. RB helped for optimizing of Oil Red assay and TG & TC measurements. MK helped for optimizing real-time PCR and analysis of data. SRH helped in editing the manuscript and designing the schematic image. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
All the authors have consented to the publication of this article.
Research involving human participants and/or animals
There are no humans or animals included in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jalilian, A., Golmohammadi, T., Meshkani, R. et al. Evaluating the effect of a mixture of two main conjugated linoleic acid isomers on hepatic steatosis in HepG2 cellular model. Mol Biol Rep 48, 1359–1370 (2021). https://doi.org/10.1007/s11033-021-06203-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06203-5